首页 | 本学科首页   官方微博 | 高级检索  
检索        


Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population
Authors:Mia Horowitz  Metsada Pasmanik-Chor  Zvi Borochowitz  Tzipora Falik-Zaccai  Keren Heldmann  Rivka Carmi  Ruth Parvari  Hannah Beit-Or  Boleslav Goldman  Lea Peleg  Ephrat Levy-Lahad  Paul Renbaum  Searl Legum  Ruth Shomrat  Hannah Yeger  Dalit Benbenisti  Ruth Navon  Vardit Dror  Mordechai Shohat  Nurit Magal  Nir Navot  Nurit Eyal
Abstract:Gaucher disease is the most prevalent inherited disease among Ashkenazi Jews. It is very heterogeneous due to a large number of mutations within the glucocerebrosidase gene, whose impaired activity is the cause for this disease. Aiming at determining Gaucher carrier frequency among the Ashkenazi Jewish population in Israel, 1,208 individuals were molecularly diagnosed for six mutations known to occur among Ashkenazi Jewish Gaucher patients, using the newly developed Pronto™ Gaucher kit. The following mutations were tested: N370S, 84GG, IVS2+1, D409H, L444P, and V394L. Molecular testing of these mutations also allows identification of the recTL allele. The results indicated that Gaucher carrier frequency is 1:17 within the tested population. The prevalence of N370S carriers is 1:17.5. This implies that ˜1:1225 Ashkenazi Jews will be homozygous for the N370S mutation. Actually, in our study of 1,208 individuals one was found to be homozygous for the N370S mutation. The actual number of known Ashkenazi Jewish Gaucher patients with this genotype is much lower than that expected according to the frequency of the N370S mutation, suggesting a low penetrance of this mutation. Results of loading experiments in cells homozygous for the N370S mutation, as well as cells homozygous for the L444P and the D409H mutations, exemplified this phenomenon. Hum Mutat 12:240–244, 1998. © 1998 Wiley-Liss, Inc.
Keywords:Gaucher disease  glucocerebrosidase  mutations  detection kit  Ashkenazi Jews
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号